Pharmaceutical Technology Ed. 191

19 Pharmaceutical Techno logy En general, el método desarrollado ofre- ce una estrategia simple y rentable para preparar una FDT de CFPD PRXL con sabor enmascarado. Los hallazgos de este estu- dio proporcionan información prometedo- ra para la industria farmacéutica a la hora de formular formas farmacéuticas orales agradables y mejorar el cumplimiento del paciente PT Referencias 1. Jain, N.; Mandal, S.; Banweer, J.; Jain, S. Effect of Superdisintegrants on Formulation of Taste Masked Fast Disintegrating Ciprofloxacin Tablets. Int. Curr. Pharm. J. 1970, 1 (4), 62–67. DOI: 10.3329/ICPJ.V1I4.10059 2. Akshay Kumar, S.; Gowda, D.V.; Sharadha, M.; Famna Roohi, N.K. Formulation and Evaluation ofThird Generation Cefpodoxime Proxetil as an Oro-Dispersible Tablet for Treating Infections. Int. J. Res. Pharm. Sci., 2020, 11 (1), 921–932. DOI: 10.26452/IJRPS.V11I1.1916 3. Patel, G.C.; Prajapati, J.; Morthana, K.M.; Khunt, D.M. Formulation and Evalua - tion of Oral Reconstitutable Suspension of Cefpodoxime Proxetil. J. Pharm. Drug Devel. 2015, 2 (1). DOI: 10.15744/2348-9782.2.101 4. Pisal, S.; Zainnuddin, R.; Nalawade, P.; Mahadik, K.; Kadam, S. Molecular Pro- perties of Ciprofloxacin-Indion 234 Complexes. AAPS PharmSciTech 2004, 5 (4), e62. DOI: 10.1208/PT050462 5. Wei, Y.; Li, C.; Zhu, Q.; et al. Comparison of Thermosensitive In-Situ Gels and Drug-Resin Complex for Ocular Drug Delivery: In-Vitro Drug Release and In- Vivo Tissue Distribution. Int. J. Pharm. 2020, 578, 119184. DOI: 10.1016/J. IJPHARM.2020.119184 6. Patel, G.C. Development of Taste-Masked Oral Reconstitutable Suspension of Cetirizine Dihydrochloride. Pharm. Technol. 2020, 44 (1), 48–52. 7. Raj, A. Formulation and In-Vitro Evaluation of Voglibose Dispersible Tablets. EJBPS 2016, 3 (2), 226–230. 8. Karanikolopoulos, N.; Goulding, P.A. Novel Pharmaceutical Composition. 16/628,463, April 23, 2020. 9. Alejandro, B.; Guillermo, T.; Ángeles, P.M. Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets. Pharmaceuticals 2020, 13 (5), 100. DOI: 10.3390/PH13050100 10. Koteeswaran, K. A Hypothetical Review of Making Sublingual Formulation by Using Kabasura Kudineer Chooranam for Prevention and Management of COVID-19 Virus. Indo. Am. J. P. Sci. 2022, 9 (7), 193–198. 11. Bhupendra, S.; Mayank, B. A Review on Orodisintegrating Tablets. IJPE 2020, 10 (1), 16–25. 12. EDQM. European Pharmacopoeia. Sixth Edition, Strasbourg, France, Jan. 1, 2008. 13. Puttewar,T.Y.; Kshirsagar, M.D.; Chandewar, A.V; Chikhale, R.V. Formulation and Evaluation of Orodispersible Tablet of Taste Masked Doxylamine Succinate Using Ion Exchange Resin. J. King Saud Univ. Sci. 2010, 22 (4), 229–240. 14. IPC. Indian Pharmacopoeia. Fourth Edition, Volume II, New Dehli, India, 1996. 15. Akash, M.S.H.; Rehman, K. Ultraviolet-Visible (UV-VIS) Spectroscopy. In Es- sentials of Pharmaceutical Analysis; Springer, Singapore, 2020; pp. 29–56. DOI: 10.1007/978-981-15-1547-7_3 16. Radke, R.; Jadhav, J.K.; Chajeed, M.R. Formulation and Evaluation of Orodis- persible Tablets of Baclofen. Int. J. Chemtech Res. 2009, 1 (3), 517–521. 17. Suryawanshi, S.D.; Thakker, S.P.; Sandesh, S.N; Ladkat, V.D.; Pandey, D.G. Formulation and Evaluation of Dispersible Tablets of Cefpodoxime Proxetil. AJPTI 2013, 1 (1), 1–12. 18. Brown, W.; Perivilli, S.; Podolsky, D.; Stippler, E.S.; Walfish, S. The Critical Role of the USP Performance Verification Test in Dissolution Testing and Qualifi- cation of the Paddle Apparatus. Dissolution Tech. 2019, February, 6–12. DOI: 10.14227/DT260119P6. 19. ICH. ICH Q1A (R2) Stability Testing of New Drug Substances and Products. Step 4 version (Feb. 6, 2003). 20. Khan, H.; Ali, A.; Ahuja, A.; Ali, J. Stability Testing of Pharmaceutical Products— Comparison of Stability Testing Guidelines. Curr. Pharm. Anal. 2010, 6 (2), 142–150. DOI: 10.2174/157341210791202627. TESTO ARGENTINA S.A.